Suppr超能文献

相似文献

1
Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma.
Clin Mol Hepatol. 2023 Apr;29(2):453-464. doi: 10.3350/cmh.2022.0450. Epub 2023 Feb 1.
2
Incidence and predictors of hepatocellular carcinoma in NAFLD without diagnosed cirrhosis: a nationwide real-world U.S. study.
Hepatol Int. 2024 Apr;18(2):540-549. doi: 10.1007/s12072-023-10616-8. Epub 2023 Dec 11.
3
Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease.
Clin Mol Hepatol. 2023 Feb;29(Suppl):S207-S219. doi: 10.3350/cmh.2022.0247. Epub 2022 Sep 14.
5
Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis.
Hepatol Commun. 2023 Jul 3;7(7). doi: 10.1097/HC9.0000000000000183. eCollection 2023 Jul 1.
6
Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis.
World J Gastroenterol. 2023 Jan 14;29(2):343-356. doi: 10.3748/wjg.v29.i2.343.
7
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
World J Gastroenterol. 2016 Oct 7;22(37):8294-8303. doi: 10.3748/wjg.v22.i37.8294.
8
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.
Liver Int. 2019 Jun;39(6):1098-1108. doi: 10.1111/liv.14087. Epub 2019 Mar 29.
10
Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.
JAMA Netw Open. 2022 Jul 1;5(7):e2223504. doi: 10.1001/jamanetworkopen.2022.23504.

引用本文的文献

1
Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation.
Eur J Clin Invest. 2025 Aug;55(8):e70059. doi: 10.1111/eci.70059. Epub 2025 May 15.
2
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment.
Clin Mol Hepatol. 2025 Feb;31(Suppl):S228-S254. doi: 10.3350/cmh.2024.0824. Epub 2024 Dec 26.
3
Access to Evaluation for Liver Transplantation in the Veterans Health Administration.
Dig Dis Sci. 2025 Feb;70(2):552-565. doi: 10.1007/s10620-024-08717-x. Epub 2024 Dec 11.

本文引用的文献

1
Increasing Incidence of Intrahepatic Cholangiocarcinoma Relative to Hepatocellular Carcinoma in the United States.
Gastro Hep Adv. 2022 Feb 3;1(2):121-124. doi: 10.1016/j.gastha.2021.10.010. eCollection 2022.
2
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
3
Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma.
Clin Mol Hepatol. 2023 Feb;29(Suppl):S220-S227. doi: 10.3350/cmh.2022.0360. Epub 2022 Nov 10.
4
Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease.
Clin Mol Hepatol. 2023 Feb;29(Suppl):S207-S219. doi: 10.3350/cmh.2022.0247. Epub 2022 Sep 14.
5
Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.
JAMA Netw Open. 2022 Jul 1;5(7):e2223504. doi: 10.1001/jamanetworkopen.2022.23504.
7
Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in the United States.
Clin Gastroenterol Hepatol. 2023 Mar;21(3):670-680.e18. doi: 10.1016/j.cgh.2022.03.010. Epub 2022 Mar 17.
9
Poor Awareness of Liver Disease Among Adults With NAFLD in the United States.
Hepatol Commun. 2021 Nov;5(11):1833-1847. doi: 10.1002/hep4.1765. Epub 2021 Jul 1.
10
Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis.
Hepatol Commun. 2021 Sep;5(9):1481-1489. doi: 10.1002/hep4.1735. Epub 2021 May 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验